Table 4.
Factor | HR | 95% CI | p-value |
---|---|---|---|
Age (ref <45 years) | |||
≥ 45 years | 4.53 | 2.66–7.70 | <0.001 |
Sex (ref=female) | |||
Male | 1.69 | 1.31–2.17 | <0.001 |
Race (ref=white) | |||
White/Hispanic | 1.08 | 0.74–1.57 | 0.685 |
Black | 1.62 | 1.14–2.32 | 0.007 |
Other | 0.63 | 0.30–1.29 | 0.211 |
Insurance status (ref=private) | |||
Uninsured | 1.35 | 0.48–3.75 | 0.559 |
Medicaid | 2.83 | 1.53–5.23 | 0.001 |
Medicare | 5.98 | 4.55–7.86 | <0.001 |
Military | 1.80 | 0.43–7.41 | 0.416 |
Tumor Size, cm (ref <1cm) | |||
≥1cm | 1.49 | 1.12–1.99 | 0.006 |
Extrathyroidal extension (ref = no) | |||
Yes | 2.41 | 1.71–3.40 | <0.001 |
Distant Metastases (ref = no) | |||
Yes | 10.38 | 5.23–20.53 | <0.001 |
Radioiodine Utilization (ref=no) | |||
Yes | 0.53 | 0.38–0.72 | <0.001 |
HR, hazard ratio; CI, confidence interval; ref, reference value
also included in the model urban/rural, facility type and location, histology